Search Results - "triathlete"

Training patterns and sports injuries in triathletes by Shaw, Therese, Howat, Peter, Maycock, Bruce, Trainor, M.

Subjects: Get full text

Neuromuscular Control and Exercise-Related Leg Pain in Triathletes by Chapman, A., Hodges, P., Briggs, Andrew, Stapley, P., Vicenzino, B.

Get full text
Get full text

Evaluation of a 7-gene genetic profile for athletic endurance phenotype in ironman championship triathletes by Grealy, R., Herruer, J., Smith, C., Hiller, D., Haseler, Luke, Griffiths, L.

“…To investigate this model's utility for elite triathletes, we genotyped seven polymorphisms previously associated with an endurance polygenic profile (ACE Ins/Del, ACTN3 Arg577Ter, AMPD1 Gln12Ter, CKMM 1170bp/985+185bp, HFEHis63Asp, GDF8 Lys153Arg and PPARGC1A Gly482Ser) in a cohort of 196 elite athletes who participated in the 2008 Kona Ironman championship triathlon. …”
Get full text

Why isn't flow-mediated dilation enhanced in athletes? by Green, D., Rowley, N., Spence, Angela

“…Subjects were elite male canoe paddlers (n = 12), squash players (n = 13), lower limb dominant athletes (i.e., runners/cyclists/triathletes, n = 13), or age- and sex-matched control subjects (n = 16). …”
Get full text

A comparison of caffeine versus pseudoephedrine on cycling time-trial performance by Spence, Angela, Sim, M., Landers, G., Peeling, P.

“…Here, 10 well-trained male cyclists or triathletes were recruited for participation. All athletes were required to attend the laboratory on four separate occasions--including a familiarization trial and three experimental trials, which required participants to complete a simulated 40 km (1,200 kJ) cycling TT after the ingestion of either 200 mg CAF, 180 mg PSE or a nonnutritive placebo (PLA). …”
Get full text
Get full text

The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes by Grealy, R., Smith, C., Chen, T., Hiller, D., Haseler, Luke, Griffiths, L.

“…Objectives: To investigate the frequency of the ACTN3 R577X polymorphism in elite endurance triathletes, and whether ACTN3 R577X is significantly associated with performance time. …”
Get full text

The Efficacy of the Lactate Threshold: A Sex-Based Comparison by Hoffmann, S., Skinner, T., van Rosendal, S., Osborne, M., Emmerton, Lynne, Jenkins, D.

“…Competitive male (mean ± SD: age, 27.7 ± 4.7 years; V[Combining Dot Above]O2max, 59.7 ± 5.2 ml·kg·min; n = 10) and female (mean ± SD: age, 27.3 ± 6.2 years; V[Combining Dot Above]O2max, 54.5 ± 5.3 ml·kg·min; n = 12) cyclists and triathletes completed an incremental cycle trial to volitional fatigue (for determination of V[Combining Dot Above]O2max and LT2 via the modified D-max method), a constant load (±5%) exercise trial of 30 minutes at LT2 power output, and a 40-km cycle time trial. …”
Get full text